Evidence map›Paper›PMID 41941753›Full record

ArticleJournal of the National Cancer Institute2026

Overlapping genetic etiology of pediatric and adult germ cell tumors.

Shannon M Sullivan, John Lane, Abigail Standafer, James Mcfeeters, Aubrey K Hubbard, Erica K Langer, Anthony J Hooten, Michelle A Roesler, Joanna J Gell, Mark Krailo and 4 more

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Overlapping genetic etiology of pediatric and adult germ cell tumors.Journal of the National Cancer Institute · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shannon M SullivanDepartment of Laboratory Medicine and Pathology, Division of Molecular Pathology and Genomics, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0003-1430-8455
John LaneDepartment of Laboratory Medicine and Pathology, Division of Computational Biology, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0002-3582-5825
Abigail StandaferDepartment of Laboratory Medicine and Pathology, Division of Computational Biology, University of Minnesota, Minneapolis, MN, United States.
James McfeetersDepartment of Laboratory Medicine and Pathology, Division of Computational Biology, University of Minnesota, Minneapolis, MN, United States.
Aubrey K HubbardDepartment of Pediatrics, Division of Epidemiology and Clinical Research, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0003-4052-1110
Erica K LangerDepartment of Pediatrics, Division of Epidemiology and Clinical Research, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0002-4528-5922
Anthony J HootenDepartment of Pediatrics, Division of Epidemiology and Clinical Research, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0003-4841-343X
Michelle A RoeslerDepartment of Pediatrics, Division of Epidemiology and Clinical Research, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0002-0844-8796
Joanna J GellCenter for Cancer and Blood Disorders, Connecticut Children's Medical Center, Hartford, CT, United States.ORCID 0000-0002-1176-8272
Mark KrailoKeck School of Medicine, University of Southern California, Los Angeles, CA, United States.
A Lindsay FrazierDana Farber Cancer Institute, Boston, MA, United States.ORCID 0000-0003-4748-8552
James F AmatrudaCancer and Blood Disease Institute, Division of Hematology-Oncology, Children's Hospital of Los Angeles, Los Angeles, CA, United States.
Nathan PankratzDepartment of Laboratory Medicine and Pathology, Division of Computational Biology, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0001-5958-693X
Jenny N PoynterDepartment of Pediatrics, Division of Epidemiology and Clinical Research, University of Minnesota, Minneapolis, MN, United States.ORCID 0000-0002-8460-3938

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Molecular Epidemiology of Pediatric Germ Cell TumorsR01CA151284 · NCI · UNIVERSITY OF MINNESOTA · PI POYNTER, JENNY N. · 2011 to 2015
$3.4M
Genetics and epigenetics of pediatric germ cell tumorsR01CA267938 · NCI · UNIVERSITY OF MINNESOTA · PI POYNTER, JENNY N. · 2022 to 2025
$1.7M
NCI NIH HHS R01 CA151284NCI NIH HHS R01 CA267938NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NIH HHS CAU10CA180886NIH HHS R01 CA151284NIH HHS R01 CA267938NIH HHS U10CA180899
6 · The paper itself

Abstract

backgroundGerm cell tumors are heterogeneous neoplasms arising from primordial germ cells. Although genome-wide association studies have identified numerous susceptibility loci for adult testicular germ cell tumors, the heritable basis of pediatric testicular germ cell tumors and germ cell tumors that arise outside the testes remain poorly understood.

methodsWe conducted a multi-ancestry genome-wide association study of pediatric germ cell tumors, including 1927 cases from the Germ Cell Tumor Epidemiology Study and 10 601 controls. Cases were diagnosed with testicular (n = 678), ovarian (n = 441), intracranial (n = 435), and extragonadal (n = 373) germ cell tumor between the ages of 0 and 19 years.

resultsWe identified 4 loci reaching genome-wide significance, including variants near BAK1 (chr 6: rs3831846), SPRY4 (chr 5: rs12515244), DMRT1 (chromosome [chr] 9: rs10815910), and DEPTOR (chr 8: rs13277786). Additional genome-wide statistically significant associations were identified in subgroup analyses, including 6 loci for intracranial germ cell tumors (rs2758612 [PMF1/BGLAP], rs9854760 [PLCL2], rs6851498 [KIT], rs11816992 on chromosome 10, rs3830273 [TFAM], and rs13054014 [LZTR1]), 1 locus for testicular germ cell tumor (rs1907702 [KITLG]), and 1 locus for males (rs4610628 [MAD1L1]). After Bonferroni correction, 18 of 78 previously reported testicular germ cell tumor loci were significantly associated with germ cell tumor overall or in at least 1 subgroup with a particularly strong correlation between testicular germ cell tumor and intracranial germ cell tumor effect estimates (rho = 0.63, P = 5.5 × 10-10). Expression quantitative trait locus (QTL) analyses identified candidate genes in the regions identified on chromosome 6 (BAK1, LINC003366, and ITPR3) and chromosome 8 (DEPTOR and RP11-760H22.2).

conclusionsOur data support a role for germline genetic variation in the development of germ cell tumors in locations outside the testes and highlight shared genetic architecture across age group and tumor location.

Indexed as

Brain NeoplasmsNeoplasms, Germ Cell and EmbryonalOvarian NeoplasmsTesticular NeoplasmsAdolescentAdultbcl-2 Homologous Antagonist-Killer ProteinCase-Control StudiesChildChild, PreschoolFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansInfantInfant, NewbornBAK1 protein, humanbcl-2 Homologous Antagonist-Killer ProteinDMRT1 proteinIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsSPRY4 protein, humanTranscription Factors

Identifiers

PMID41941753
PMCPMC13422894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.